Our results show that the colonic BEV fractions of UC patients are characterized by high IgA-titers, high IgA-receptor (CD89)-IgA complex levels, and strong CD89-dependent inflammatory responses, which correlate with the extent of colonic inflammation in patients. This evidence concerns the gene FCAR and inflammatory response.